• Nie Znaleziono Wyników

White blood cell count to mean platelet volume ratio as a novel blood cell parameter. Authors’ reply

N/A
N/A
Protected

Academic year: 2022

Share "White blood cell count to mean platelet volume ratio as a novel blood cell parameter. Authors’ reply"

Copied!
1
0
0

Pełen tekst

(1)

White blood cell count to mean platelet volume ratio as a novel blood cell parameter. Authors’ reply

We would like to thank Çelik et al. [1] for the reply to our article “White blood cell count to mean platelet volume ratio: A novel and promis- ing prognostic marker for ST-segment elevation myocardial infarction” [2]. Herein, we wish to make some contributions to their valuable comments. As previously stated, there is a strong discussion on the relationship between blood cell parameters and outcomes in patients with coronary artery disease (CAD) [3–5]. These parameters can be useful in predicting the prognosis in patients with acute coronary syndromes (ACS). It is noteworthy, that novel biomarkers measured by clinicians could potentially provide additional information to the decision-making process and treatment strategy [4]. Indeed, there is growing body of research sup- porting the hypothesis that white blood cell count to mean platelet volume ratio (WMR) could be a new prognostic indicator that contains these three properties [2, 6]. However, long-term follow-up and large-scale prospective further studies are strongly needed to clarify and prove the predictive value of WMR in patients with CAD and ACS.

Conflict of interest: None declared

References

1. Celik T, Balta S, Ozturk C, Iyisoy A. Whole blood cell parameters help us to predict the prognosis in patients with acute ST seg- ment elevation myocardial infarction: Myth or reality? Cardiol J, 2016; 23: 357–358. doi: 10.5603/CJ.2016.0037.

2. Çiçek G, Açıkgöz SK, Yayla Ç, Kundi H, İleri M. White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for ST-segment elevation myocardial infarc- tion. Cardiol J, 2016; 23: 225–235. doi: 10.5603/CJ.a2016.0001.

3. Yayla C, Akboga MK, Canpolat U et al. Platelet to lymphocyte ratio can be a predictor of infarct-related artery patency in pa- tients with ST-segment elevation myocardial infarction. Angiol- ogy, 2015; 66: 831–836.

4. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation, 2007; 115: 949–

–952.

5. Doehner W. Diagnostic biomarkers in cardiovascular disease:The proteomics approach. Eur Heart J, 2012; 33: 2249–2251.

6. Dehghani MR, Rezaei Y, Taghipour-Sani L. White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome. Cardiol J, 2015; 22: 437–445.

doi: 10.5603/CJ.a2015.0015.

Gokhan Cicek

1

, Cagri Yayla

2

1

Ankara Numune Training and Research Hospital, Cardiology Clinic, Ankara, Turkey, tel: +90 5052485345, e-mail: drvaristor@hotmail.com

2

Türkiye Yüksek Ihtisas Training and Research Hospital, Cardiology Clinic, Ankara, Turkey

359 www.cardiologyjournal.org

LETTER TO THE EDITOR

Cardiology Journal 2016, Vol. 23, No. 3, 359 DOI: 10.5603/CJ.2016.0038 Copyright © 2016 Via Medica ISSN 1897–5593

Cytaty

Powiązane dokumenty

Można szacować, że w grupie pacjentów ze STEMI leczonych optymalnie — zgodnie z aktualnie obo- wiązującymi standardami ESC — SBP powyżej 130 mm Hg podczas pierwszego

Na podstawie dokumentacji medycznej oceniano: czas trwania nadciśnienia, palenie tytoniu, spożywanie alkoholu, wartości ciśnienia tętniczego mierzone metodą Ko- rotkowa w

intermediate risk (Bonferroni correction); CABG — coro- nary artery bypass grafting; CS — cardiogenic shock; LVEF — left ventricular ejection fraction; MI — myocardial

Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.. Dogra G, Rich L, Stanton K,

In that well-designed article, the authors aimed to evalu- ate the predictive value of admission white blood cell count (WBC) to mean platelet volume (MPV) ratio (WMR) on

Hence, in this prospective study, we sought to determine whether the baseline white blood cell (WBC) count to mean platelet volume ratio (WMR) can predict the long-term outcomes in

White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary

In recent years, there has been growing interest in descri- bing useful markers to predict adverse outcomes in patients with solid malignancies such as mean platelet volume (MPV)